Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Correction: Crystal structures of human procathepsin H.

Hao Y, Purtha WE, Cortesio C, Rui H, Gu Y, Chen H, Sickmier EA, Manzanillo PS, Huang X.

PLoS One. 2019 Jun 10;14(6):e0218063. doi: 10.1371/journal.pone.0218063. eCollection 2019.

2.

Tolerance is established in polyclonal CD4(+) T cells by distinct mechanisms, according to self-peptide expression patterns.

Malhotra D, Linehan JL, Dileepan T, Lee YJ, Purtha WE, Lu JV, Nelson RW, Fife BT, Orr HT, Anderson MS, Hogquist KA, Jenkins MK.

Nat Immunol. 2016 Feb;17(2):187-95. doi: 10.1038/ni.3327. Epub 2016 Jan 4.

3.

Spontaneous mutation of the Dock2 gene in Irf5-/- mice complicates interpretation of type I interferon production and antibody responses.

Purtha WE, Swiecki M, Colonna M, Diamond MS, Bhattacharya D.

Proc Natl Acad Sci U S A. 2012 Apr 10;109(15):E898-904. doi: 10.1073/pnas.1118155109. Epub 2012 Mar 19.

4.

Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants.

Purtha WE, Tedder TF, Johnson S, Bhattacharya D, Diamond MS.

J Exp Med. 2011 Dec 19;208(13):2599-606. doi: 10.1084/jem.20110740. Epub 2011 Dec 12.

5.

Tregs control the development of symptomatic West Nile virus infection in humans and mice.

Lanteri MC, O'Brien KM, Purtha WE, Cameron MJ, Lund JM, Owen RE, Heitman JW, Custer B, Hirschkorn DF, Tobler LH, Kiely N, Prince HE, Ndhlovu LC, Nixon DF, Kamel HT, Kelvin DJ, Busch MP, Rudensky AY, Diamond MS, Norris PJ.

J Clin Invest. 2009 Nov;119(11):3266-77. doi: 10.1172/JCI39387. Epub 2009 Oct 12.

6.

Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity.

Hildner K, Edelson BT, Purtha WE, Diamond M, Matsushita H, Kohyama M, Calderon B, Schraml BU, Unanue ER, Diamond MS, Schreiber RD, Murphy TL, Murphy KM.

Science. 2008 Nov 14;322(5904):1097-100. doi: 10.1126/science.1164206.

7.

Early B-cell activation after West Nile virus infection requires alpha/beta interferon but not antigen receptor signaling.

Purtha WE, Chachu KA, Virgin HW 4th, Diamond MS.

J Virol. 2008 Nov;82(22):10964-74. doi: 10.1128/JVI.01646-08. Epub 2008 Sep 10.

8.

Tumor necrosis factor alpha protects against lethal West Nile virus infection by promoting trafficking of mononuclear leukocytes into the central nervous system.

Shrestha B, Zhang B, Purtha WE, Klein RS, Diamond MS.

J Virol. 2008 Sep;82(18):8956-64. doi: 10.1128/JVI.01118-08. Epub 2008 Jul 16.

9.

Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes.

Sukupolvi-Petty S, Austin SK, Purtha WE, Oliphant T, Nybakken GE, Schlesinger JJ, Roehrig JT, Gromowski GD, Barrett AD, Fremont DH, Diamond MS.

J Virol. 2007 Dec;81(23):12816-26. Epub 2007 Sep 19.

10.

Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis.

Purtha WE, Myers N, Mitaksov V, Sitati E, Connolly J, Fremont DH, Hansen TH, Diamond MS.

Eur J Immunol. 2007 Jul;37(7):1845-54.

11.

General deoxyribozyme-catalyzed synthesis of native 3'-5' RNA linkages.

Purtha WE, Coppins RL, Smalley MK, Silverman SK.

J Am Chem Soc. 2005 Sep 28;127(38):13124-5.

PMID:
16173722
12.

Zn2+-dependent deoxyribozymes that form natural and unnatural RNA linkages.

Hoadley KA, Purtha WE, Wolf AC, Flynn-Charlebois A, Silverman SK.

Biochemistry. 2005 Jun 28;44(25):9217-31.

Supplemental Content

Loading ...
Support Center